During a characteristically bizarre and rambling press conference, Donald Trump yesterday fought back against lurid reports from Russia, but two policies nevertheless emerged as priorities:
A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
